Trials / Conditions / Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin's Lymphoma (NHL)

17 registered clinical trials studyying Non-Hodgkin's Lymphoma (NHL) — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients NCT06665737	Department of Medical Services Ministry of Public Health of Thailand	Phase 4
Terminated	Study of XL114 in Subjects With Non-Hodgkin's Lymphoma NCT05144347	Exelixis	Phase 1
Unknown	Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) NCT04696705	Institute of Hematology & Blood Diseases Hospital, China	EARLY_Phase 1
Completed	Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors NCT02071888	Calithera Biosciences, Inc	Phase 1
Unknown	Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transpla NCT01983761	Targazyme, Inc.	Phase 1 / Phase 2
Completed	Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders NCT01758042	Massachusetts General Hospital	N/A
Completed	Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit NCT01527838	Fate Therapeutics	Phase 1
Completed	Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Pre NCT01108341	Cephalon	Phase 2
Completed	Tumor Registry of Lymphatic Neoplasia NCT00889798	iOMEDICO AG	—
Completed	Zevalin Post-marketing Surveillance in Japan NCT01448928	Spectrum Pharmaceuticals, Inc	—
Completed	Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan NCT01479387	Bayer	—
Completed	Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood NCT00923910	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lympho NCT00614042	Aptevo Therapeutics	Phase 1
Completed	Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma NCT00511082	Otsuka Beijing Research Institute	Phase 1
Terminated	Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL NCT00089284	Northwestern University	Phase 1 / Phase 2
Completed	Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's L NCT00129090	German High-Grade Non-Hodgkin's Lymphoma Study Group	Phase 3
Terminated	Haploid Allogeneic Transplant Using the CliniMACS System NCT00185679	Ginna Laport	Phase 2